IntraOp

Sunnyvale, United States Founded: 1993 • Age: 33 yrs Acquired By Firsthand Technology Value Fund
Intraoperative electron radiation therapy for cancer treatment is delivered.

About IntraOp

IntraOp is a Healthcare company based in Sunnyvale (United States) founded in 1993, and was acquired by Firsthand Technology Value Fund in October 2013. Intraoperative electron radiation therapy for cancer treatment is delivered. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its competitors include RefleXion, Mevion Medical Systems and ZAP-X; 3 of its 3 listed competitors have raised funding.

Company details

IntraOp Medical Corporation provides technology solutions for the treatment and eradication of cancer. It offers Mobetron, a medical device that delivers intra-operative electron radiation therapy (IOERT) for the treatment of various cancer types. This device is used extensively in hospitals, university research centers, and specialized cancer clinics in North America, Europe and Asia. IntraOp received U.S. Food and Drug Administration (FDA) approval for the Mobetron in 1998, and in 2013 Medicare (US gov) approved reimbursement for electron IORT. IntraOp was acquired by First Hand Technology Value Fund on 8th October, 2013.

Operational Areas
Key Metrics

Apps and channels of IntraOp

its YouTube channel IntraOp Medical Corporation has 9.59K subscribers and 30 videos.

IntraOp Medical Corporation
YouTube 9.59K subscribers 30 videos Science & Technology
Open channel

Videos from IntraOp

The most watched videos on IntraOp's YouTube channel, IntraOp Medical Corporation (9.59K subscribers). Click a video to play it here.

IntraOp Electron Therapy for Skin Cancer
11.2K views
IntraOp Demonstration: FLASH with electrons (FOR INVESTIGATIONAL USE ONLY)
5.5K views
Image-Guided Electron Therapy
4.3K views
Image-Guided Electron Therapy
3.5K views

More on IntraOp Medical Corporation.

Funding Insights of IntraOp

  • Total Rounds 7
  • Last Round Debt – Conventional β€” $3.6M
  • First Round $4.5M

    (Nov 2005)

All 7 funding rounds of IntraOp with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2009$3.6MDebt – Conventional––
–
Jul 2009$3.6MPost-IPO––
–
Jun 2008$900,000Post-IPO––
–
Feb 2008$2.37MPost-IPO––
–
Nov 2007$5.4MPost-IPO––
–
Jun 2007$1.2MPost-IPO––
–
Nov 2005$4.5MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in IntraOp

IntraOp has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Firsthand Technology Value Fund.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Sector-agnostic venture capital investments are made in technology companies.
1994firsthandtvf.comSan Jose, United States
Premium access

Investor details for IntraOp

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of IntraOp

15 people are tracked at IntraOp (6 in leadership, 9 in team).

NameRoleGroup
An Nguyen
Director of Regulatory Affairs and Quality AssuranceLeadership
Mike Vickers MBA
Director Sales & Business Development, USLeadership
Marc Swallyee
Director European Services & Customer SupportLeadership
Sal Gonzalez
Director Of OperationsLeadership
Richard Johnson
Director of Control System EngineeringLeadership
Kristi Taylor
Director, Clinical SolutionsLeadership
Anoill Youkhaneh EIT
Sr. Manager Service OperationsTeam
Jenny L
ControllerTeam
Jack Urban
Senior Field Service Service EngineerTeam
Tram Nguyen
AccountantTeam
John Carter
Sales Marketing CoordinatorTeam
Madison MacEocain
Marketing CoordinatorTeam
Teddy Borg
Mechanical Inspection LeadTeam
Jorge L Martinez
Electro Mechanical TechnicianTeam
Philip von Voigts Rhetz
Clinical Application SpecialistTeam
Premium access

Complete people profiles for IntraOp

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of IntraOp

4 dated milestones of IntraOp across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded IntraOp is founded.
  2. Funding First funding round of $4.5M.
  3. Funding Latest funding round, Debt – Conventional, of $3.6M.
  4. Exit Acquired by Firsthand Technology Value Fund.

Competitors of IntraOp

IntraOp has 3 listed competitors in our database, 3 of them funded. They include RefleXion, Mevion Medical Systems and ZAP-X.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
reflexion.com2009Hayward, United States$553.91M257
Biology-guided radiotherapy systems are provided for cancer treatment.
mevion.com2004Littleton, United States$500.18M136
Proton therapy systems are supplied for cancer radiation treatment.
zapsurgical.com2014San Carlos, United States$159M
Developer of gyroscopic radiosurgery platform
Premium access

Detailed competitors of IntraOp

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of IntraOp

The website of IntraOp (intraop.com) receives about 3.6K visits a month.

  • Monthly visits
    3.6K

    ▲ 188.3% vs previous month

Top companies in Oncology

3 companies that operate in the same segment as IntraOp (Oncology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Intraop

Premium access

Complete news archive for IntraOp

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IntraOp

IntraOp was founded in 1993 and raised its 1st funding round 12 years after it was founded.

IntraOp is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.

IntraOp Medical Corporation provides technology solutions for the treatment and eradication of cancer. It offers Mobetron, a medical device that delivers intra-operative electron radiation therapy (IOERT) for the treatment of various cancer types. This device is used extensively in hospitals, university research centers, and specialized cancer clinics in North America, Europe and Asia. IntraOp received U.S. Food and Drug Administration (FDA) approval for the Mobetron in 1998, and in 2013 Medicare (US gov) approved reimbursement for electron IORT. IntraOp was acquired by First Hand Technology Value Fund on 8th October, 2013.

IntraOp's top competitors include RefleXion, ZAP-X and Mevion Medical Systems.

IntraOp has 1 investor. Key investors include Firsthand Technology Value Fund.

Yes. IntraOp was acquired by Firsthand Technology Value Fund in October 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available